Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Journal of Infection and Public Health
|
August 4, 2022
Changes in the user profiles of HIV pre-exposure prophylaxis (PrEP) before and after PrEP reimbursement
Patrick Ahaus, Axel J Schmidt, Adriane Skaletz-Rorowski, et al.
Biomed Research International
|
May 21, 2016
Prevalence and Influencing Factors of Thyroid Dysfunction in HIV-Infected Patients
Shujing Ji, Changzhong Jin, Stefan Höxtermann, et al.
HIV Clinical Trials
|
July 14, 2016
Severe dyslipidemia and immune activation in HIV patients with dysglycemia
Changzhong Jin, Shujing Ji, Tiansheng Xie, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|
October 19, 2021
[Sexual behavior and prevention of sexually transmitted infections taking the SARS-CoV-2 pandemic into account. Data from a sexual healthcare and medicine center-WIR]
Norbert H Brockmeyer, Anja Potthoff, Wiltrud Knebel-Brockmeyer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 13, 2023
Humoral and cellular immune responses to repeated SARS-CoV-2 infection and vaccination in an individual living with HIV
Agit Simsek, Clara Bessen, Toni L Meister, et al.
Frontiers in Immunology
|
December 19, 2022
Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIV
Clara Bessen, Carlos Plaza-Sirvent, Agit Simsek, et al.
The Journal of Antimicrobial Chemotherapy
|
July 1, 2011
Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens
Christoph Wyen, Heidy Hendra, Marco Siccardi, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
December 2, 2015
Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013
, Amanda Mocroft, Jens Lundgren, et al.
Ebiomedicine
|
June 15, 2020
DRH1 - a novel blood-based HPV tumour marker
Thomas Weiland, Alexander Eckert, Peter Valentin Tomazic, et al.
Plos Medicine
|
October 19, 2013
Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)
Amanda Mocroft, Jens D Lundgren, Miriam Lewis Sabin, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Journal of Infection and Public Health
|
August 4, 2022
Changes in the user profiles of HIV pre-exposure prophylaxis (PrEP) before and after PrEP reimbursement
Patrick Ahaus, Axel J Schmidt, Adriane Skaletz-Rorowski, et al.
Biomed Research International
|
May 21, 2016
Prevalence and Influencing Factors of Thyroid Dysfunction in HIV-Infected Patients
Shujing Ji, Changzhong Jin, Stefan Höxtermann, et al.
HIV Clinical Trials
|
July 14, 2016
Severe dyslipidemia and immune activation in HIV patients with dysglycemia
Changzhong Jin, Shujing Ji, Tiansheng Xie, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|
October 19, 2021
[Sexual behavior and prevention of sexually transmitted infections taking the SARS-CoV-2 pandemic into account. Data from a sexual healthcare and medicine center-WIR]
Norbert H Brockmeyer, Anja Potthoff, Wiltrud Knebel-Brockmeyer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 13, 2023
Humoral and cellular immune responses to repeated SARS-CoV-2 infection and vaccination in an individual living with HIV
Agit Simsek, Clara Bessen, Toni L Meister, et al.
Frontiers in Immunology
|
December 19, 2022
Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIV
Clara Bessen, Carlos Plaza-Sirvent, Agit Simsek, et al.
The Journal of Antimicrobial Chemotherapy
|
July 1, 2011
Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens
Christoph Wyen, Heidy Hendra, Marco Siccardi, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
December 2, 2015
Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013
, Amanda Mocroft, Jens Lundgren, et al.
Ebiomedicine
|
June 15, 2020
DRH1 - a novel blood-based HPV tumour marker
Thomas Weiland, Alexander Eckert, Peter Valentin Tomazic, et al.
Plos Medicine
|
October 19, 2013
Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)
Amanda Mocroft, Jens D Lundgren, Miriam Lewis Sabin, et al.
Page
of 5